Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
As of July 16, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年7月16日，医疗保健板块的三只股票可能对那些将动量视为交易决策关键标准的投资者发出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一种动量指标，它将股票在股价上升的日子里的强度与在股价下跌的日子里的强度进行比较。与股票价格的走势相比，它可以让交易员更好地了解股票在短期内的表现。当RSI高于70时，资产通常被认为是超买的，据Benzinga Pro称。
Here's the latest list of major overbought players in this sector.
以下是行业中超买的主要股票列表。
Aveanna Healthcare Holdings Inc (NASDAQ:AVAH)
Aveanna Healthcare Holdings Inc（纳斯达克:AVAH）
- On May 9, Aveanna Healthcare posted a narrower-than-expected quarterly loss. Jeff Shaner, Chief Executive Officer, commented, "Our first quarter results reflect the continued positive momentum at Aveanna, highlighted by revenue and Adjusted EBITDA growth of 5.2% and 22.5% respectively, when compared to the prior year period." The company's stock gained around 38% over the past five days and has a 52-week high of $3.66.
- RSI Value: 76.61
- AVAH Price Action: Shares of Aveanna Healthcare gained 10.3% to close at $3.52 on Monday.
- 5月9日，Aveanna Healthcare发布了一份比预期亏损小的季度财报。首席执行官Jeff Shaner评论道：“我们的第一季度业绩反映了Aveanna的持续积极势头，与去年同期相比，营业收入和调整后的EBITDA分别增长了5.2%和22.5%。”该公司的股票在过去五个交易日内上涨了约38%，52周高点为3.66美元。
- RSI价值: 76.61
- AVAH价格走势：Aveanna Healthcare的股价于周一收盘上涨10.3%，报3.52美元。
Revolution Medicines Inc (NASDAQ:RVMD)
revolution medicines公司 （纳斯达克:RVMD）
- On July 12, Barclays analyst Peter Lawson initiated coverage on Revolution Medicines with an Overweight rating and announced a price target of $52. The company's stock gained around 24% over the past month and has a 52-week high of $48.61.
- RSI Value: 75.60
- RVMD Price Action: Shares of Revolution Medicines gained 1.9% to close at $46.00 on Monday.
- 7月12日，巴克莱分析师彼得·劳森（Peter Lawson）开始为革命医药公司进行覆盖，评级为“增持”并公布了52美元的目标价。该公司的股票在过去一个月内上涨了约24%，52周高点为48.61美元。
- RSI价值: 75.60
- RVMD价格走势：革命医药公司的股价于周一上涨了1.9%，报46.00美元。
Fulcrum Therapeutics Inc (NASDAQ:FULC)
fulcrum therapeutics公司 （纳斯达克:FULC）
- On July 10, Cantor Fitzgerald analyst Kristen Kluska reiterated Fulcrum Therapeutics with an Overweight and maintained a $23 price target. The company's stock gained around 40% over the past five days and has a 52-week high of $13.70.
- RSI Value: 70.72
- FULC Price Action: Shares of Fulcrum Therapeutics gained 5.5% to close at $8.45 on Monday.
- 7月10日，康泰菲分析师克里斯汀·克鲁斯卡（Kristen Kluska）重申了对Fulcrum Therapeutics的“增持”评级，并维持了23美元的价格目标。该公司的股票在过去五个交易日内上涨了约40%，52周高点为13.70美元。
- RSI价值: 70.72
- FULC价格走势：Fulcrum Therapeutics的股价于周一上涨了5.5%，收于8.45美元。
- Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
- 美国银行、大摩资源lof和其他3只股票将在周二受到关注